Background Controversy exists regarding the ideal method of reconstruction after proximal humeral resection and several reconstructive techniques have been reported. The reconstructive options are very limited when resection of the entire humerus is required. One option is endoprosthetic reconstruction, but there have been few published studies on the outcome of total humeral endoprosthetic reconstruction.
Introduction
The proximal humerus is the third most common site for primary sarcoma of bone. The proximal humerus and the diaphysis are also common locations for skeletal metastasis. However, tumors necessitating total humeral resection are rare. Between 1970 and 2013, we carried out a total of 2495 endoprosthetic replacements with total humeral replacements representing \ 2% of these procedures.
Controversy still exists regarding the ideal method of reconstruction after proximal humeral resection and several reconstructive techniques have been reported, including endoprosthetic reconstruction, allograft-prosthetic composites, osteoarticular allografts, recycled autografts, clavicula pro humero, vascularized fibular grafts, pedicled scapular crests autografts, or combined fibular graft with allograft/recycled autograft [1, 3, 6-8, 17, 19, 22, 24-26, 28, 29, 32, 33] . Endoprosthetic reconstruction yields satisfactory results after resection of the tumors of the distal end of the humerus [11, 12, 16, 30, 31, 34] . Diaphyseal bone defects after tumor resection can be reconstructed with an endoprosthesis, allograft, recycled autograft, or vascularized fibular grafts [2, 18, 21] . However, the reconstructive options are very limited when the tumor extension requires resection of the entire humerus and include total humeral allograft with a proximal humeral prosthesis (allograft-prosthetic composite) and endoprosthetic reconstruction. There have been few published studies on the outcome of total humeral endoprosthetic reconstruction [5, 14, 23, 27, 34, 35] .
The purposes of this study were (1) to assess the longevity of total humerus prostheses in those patients who survived their disease; (2) to review the complications associated with this prosthesis; and (3) to assess the Musculoskeletal Tumor Society functional score in survivors.
Patients and Methods
Between September 1970 and October 2012, 35 patients underwent total humeral endoprosthetic replacement in our institution. One patient had this procedure for fracture nonunion and was excluded from the study leaving 34 patients in this study. There were 24 female patients and 10 male patients with a mean age of 26 years (range, 7-86 years) at the time of implant insertion ( Table 1 ). The histological diagnosis was osteosarcoma in 15 patients, chondrosarcoma in seven, Ewing's sarcoma in seven, metastatic carcinoma in three, liposarcoma in one, and giant cell tumor in one remaining patient. Eleven patients (32%) had a pathological fracture at presentation. All patients were followed up for a minimum of 3 months (mean, 8 years; range, 3 months to 29 years). Patients who had less than 2 years of followup (10 patients) were those who died before 2 years from their procedure. Patients were reviewed every 3 months for the first 2 years, 6monthly in Years 3 to 5, and yearly thereafter.
All patients had preoperative staging studies including plain radiographs of the arm, CT of the lungs, 99m Tc bone scan, and, since 1992, MRI of the arm for evaluation of tumor extent. Patients with a diagnosis of osteosarcoma or Ewing's sarcoma received preoperative and postoperative adjuvant chemotherapy according to the protocol in which the unit was involved at the time of treatment.
Local recurrence was seen in five patients at a mean of 15 months from the index procedure (range, 4-28 months), and all eventually died of disease progression. Seven patients had distant metastasis (pulmonary and/or skeletal) at the time of implant insertion, whereas metastatic disease was identified in another nine patients at a mean of 17 months (range, 7-48 months) after the index procedure. Thirteen of those 16 patients with identified distant metastasis died of their disease. One patient with pulmonary metastasis died of chemotherapy-induced cardiomyopathy.
A custom-made total humeral endoprosthetic replacement (THER) was used in 24 patients (71%) and an expandable THER (Stanmore Implants Worldwide Ltd, Elstree, UK) in the remaining 10 patients (29%). Two patients received THERs with a reverse shoulder design ( Fig. 1 ). Fourteen patients had reconstruction of the capsular ring with a synthetic mesh around the humeral head. This allows postoperative soft tissue integration, thus reducing the risk of humeral head subluxation.
Twenty-nine patients (85%) had their THERs for primary reconstruction, whereas the remaining five patients had their THERs as a salvage procedure for failed previous reconstructive techniques after tumor resections, including two patients with failed intramedullary nailing and palliative radiotherapy for metastatic disease (Fig. 2 ), one with a late recurrence of a distal humerus giant cell tumor that had been treated with an endoprosthesis, and two children (ages 8 and 12 years at the time of THER) who were treated for failed, irradiated autografts that were used for primary malignancies of bone.
Statistical Analysis
This was performed on StatView 1 (Version 5.0.1) software (SAS Institute Inc, Cary, NC, USA). Survival analysis was carried out using Kaplan-Meier survival plots. Table 1 . Operative Technique A THER is performed for those cases in whom the osseous/ soft tissue tumor extension would not allow for preservation of a bone segment either proximally or distally that would allow for endoprosthetic reconstruction (either proximal or distal humeral) after tumor resection. This is particularly seen in (1) large diaphyseal neoplasms extending proximally and distally into the metaphyses; (2) metaphyseal neoplasms with skip lesions at the opposite end of the humeral bone; (3) cases with extensive bone destruction; and (4) patients presenting with pathological fractures or those undergoing secondary reconstruction where widespread contamination of the surrounding tissues is likely. Surgical exposure in all cases was made using the extensile exposure described by Henry [13] .
A decision on whether the deltoid muscle (or part of it) could be saved is made based on the extraosseous tumor extension on the preoperative MRI. After removal of the humerus, the proximal ulna is prepared to receive the ulnar component of the prosthesis, which is cemented in place. The elbow was originally a fixed-hinge design (21 patients), but for the past 15 years, a floppy hinge has been used (12 patients). A custom-made prosthesis with a hemiarthroplasty design at the elbow was used in one patient (Fig. 1C ). Since 1998, we routinely used either a polyester knitted nonabsorbable undyed mesh (Mersilene; Johnson & Johnson International, Brussels, Belgium) or a MUTARS 1 reattachment tube (Implantcast GmbH, Buxtehude, Germany) for capsular reconstruction of the shoulder around the humeral head of the prosthesis. This capsular reconstruction was performed in 14 patients (41%), whereas it was not required in those two patients who received a THER with a reverse shoulder design. Soft tissue reconstruction is achieved by suturing the divided tendons, ie, rotator cuff tendons, pectoralis major, subscapularis, latissimus dorsi, and teres major, to either the prosthesis or the reattachment tube using nonabsorbable Ethibond suture (Ethicon; Johnson & Johnson Medical Ltd, Livingston, UK). The arm is placed in a sling for 4 weeks and early ROM exercises to the elbow are started. Passive ROM exercises of the shoulder are started at 4 weeks followed by active exercises at 6 weeks postoperatively.
Results
At latest followup, 16 patients were alive with their prosthesis and no evidence of disease. Twenty-eight patients had a minimum of 1 year followup after implant insertion and could be assessed (average, 10 years; range, 1.3-29 years). There were no cases of implant breakage or failure. The cumulative implant survival rate according to Kaplan-Meier was 90% at 5 and 10 years ( Fig. 3) .
Postoperative radial nerve palsy was seen in one patient. Six of the 10 patients with expandable THERs underwent a total of 19 lengthening procedures of their implants. One patient developed a humeral head dislocation after 1.7-cm lengthening of her prosthesis. She had an open reduction of the humeral head with acute shortening of the prosthesis and reconstruction of the capsular ring using a MUTARS 1 attachment tube. Superior subluxation of the humeral head was seen in another two patients in whom an attachment tube was not used at the time of the primary reconstruction, and both did not require any further surgical intervention.
The mean Musculoskeletal Tumor Society functional score [10] at last followup was 83% (range, 60%-93%). All of our patients had limited active ROM of their shoulders at the time of the latest followup. None of our patients was able to actively elevate the shoulder to more than 60°in the sagittal, coronal, or scapular plane. Twelve patients had an average flexion deformity of the elbow of 15°(range, 10°-30°) but only three patients had active elbow flexion of less than 100°. Patients reported functional limitations with activities involving pulling, pushing, lifting, and raising the arm above the shoulder level. All patients maintained good hand function.
Discussion
In the past, extremity sarcomas routinely were treated by amputation, but the improved effectiveness of chemotherapy, developments in imaging modalities, and advances in surgical reconstructive techniques have resulted in most of the patients with sarcoma being candidates for limb salvage surgery [9] . A THER is only called for in those patients with extensive bone and soft tissue involvement requiring resection of the entire humerus to achieve local control. However, when called for, it is an important tool in the surgeon's armamentarium, and the case series on it [23, 27] are small or limited in terms of the available followup. There is very little known about the longevity of total humeral endoprosthetic replacement and the functional outcome after this type of reconstruction. In this study, the 10-year implant survival rate was 90% in those patients who survived their tumor. We had an acceptable rate of complications with this reconstructive technique. Although the functional scores on the Musculoskeletal Tumor Society instrument were not always high, they nonetheless allowed patients to retain a functional extremity when amputation might have been the alternative approach.
This study has the following limitations: the primary limitations include the retrospective nature of this study and the small number of patients resulting from the limited indications for this type of reconstruction. Moreover, six of our patients (18%) died of their disease less than 1 year from the time of implant insertion and therefore could not be included in the functional assessment of this patient population. Additionally, the heterogeneity of the diagnoses in this patient population, the use of the different type of implants (adults versus growing implants and conventional versus reverse shoulder implants), and the different surgical indications (primary versus secondary reconstruction) have all contributed to the limited conclusions that could be drawn from the present study.
Of the 34 patients who underwent THER in our series, 28 had implants available for assessment at followup. The cumulative 5-year implant survival rate in our series of 90% is comparable to the 95% 5-year implant survival rate reported by Puri and Gulia [27] . The reconstructive options are very limited after total humeral resections. The use of allograft-prosthetic composites have been previously reported [34] . Biomechanically, massive allografts can function as a structural unit in the absence of advanced revascularization and creeping substitution [4] . The same concept applies to recycled autografts. We have had limited success with the use of irradiated total humeral autografts, and two of the four patients sustained a fracture through the irradiated bone. We failed to get either of these two fractures to unite, possibly as a result of the absence of a graft-host bone junction, which allows for graft union and incorporation by creeping substitution, and both reconstructions were eventually converted to THERs.
Three patients in our series had a change of their elbow polyethylene bushings after a mean of 16 years. There was no report of a change of the elbow bushings in the two previously published series of THERs [23, 27] . This could possibly be related to the shorter mean followup in each of these two studies (3.4 and 5.5 years, respectively) as compared with 8.2 years in our series. Hanna et al. [12] reported on 18 cases with distal humeral endoprosthetic replacements with change of the polyethylene bushings in two cases (11%) at an average of 4.8 years. Similarly, Kulkarni et al. [16] reported changes of polyethylene bushings in three of 10 (30%) patients with distal humeral endoprosthetic replacement at a mean followup of 7 years.
Four patients in this study had periprosthetic infection. Two of these patients had their THER for failed previous reconstructive techniques, one of whom had deep infection around the previous distal humeral implant, but a decision to proceed with a one-stage revision was based on the negative cultures of preoperative aspirate and normal inflammatory markers (erythrocyte sedimentation rate = 3 mm/hour, and C-reactive protein \ 3 mg/dL) at the time of revision surgery. Our results match those reported by Weber et al. [34] who reported that 9% of their patients developed periprosthetic infection. There were no reports of deep infection in either the series by Puri and Gulia [27] or Natarajan et al. [23] of primary THERs. Proximal migration of the prosthetic head was seen in three cases of our series. There were no apparent differences between adult and expandable prostheses because two of these were in adult prostheses and one was in an expandable implant. This problem has been reported in many other series after proximal humeral and THERs [6, 7, 23] . We have not observed any significant humeral head subluxation in patients who had primary reconstruction of the capsular ring with either a Mersilene mesh or MUTARS 1 reattachment tube. Subluxation of the humeral head was not also seen in any of those patients with tumors not involving the soft tissue stabilizers of the glenohumeral joint. Marulanda et al. [20] observed no shoulder dislocations in their series of 16 patients with proximal humeral replacement reconstructed with an aortograft mesh. They found that the sleeve created by the aortograft allows for mechanical restraint and facilitates soft tissue reconstruction after tumor resection. Puri and Gulia [27] reported a similar experience with no observed shoulder dislocations in their series of 20 patients with THERs and capsular reinforcement using polypropylene mesh. Raiss et al. [28] had four cases of humeral head dislocation in their series of 39 patients with proximal humeral endoprosthetic replacement and soft tissue reconstruction using a Trevira tube (Implantcast GmbH). However, the authors stated that they did not reattach any of the rotator cuff tendons in 10 of their patients [28] . We have not observed an improvement in active ROM of the shoulder in the two patients who had their THERs with a reverse shoulder design. Local recurrence was seen in five of our 29 patients (17%) who received THERs for primary sarcomas of bone. Our findings compare favorably to those reported by Natarajan et al. [23] (20%) and Puri and Gulia [27] (26%). Four of the five recurrences in our series were seen in those 15 patients with a histological diagnosis of osteosarcoma (27%) and two of them had metastatic disease at diagnosis. It is possible that the larger tumor volume in these patients necessitating resection of the entire humerus might explain the higher local recurrence rates to those reported in other anatomical locations. However, this has been found to have only a small effect on the overall survival in patients with high-risk extremity osteosarcoma [15] . The observation that all patients in this series who developed local recurrence died is in part the result of the fact that two of four patients with osteosarcoma had metastatic disease at diagnosis.
The consistently limited active ROM of the shoulder after proximal humeral and THERs has been reported by many authors [6, 7, 17, 23, 27, 28] . Careful soft tissue reconstruction with reattachment of the rotator cuff tendons did not seem to improve the results. Despite the poor movement at the shoulder, patients had excellent manual dexterity and functional use of their hands with good to excellent Musculoskeletal Tumor Society functional scores (mean, 83%; average, 60%-93%). We have not observed an improvement in active ROM of the shoulder in the two patients who had their THERs with a reverse shoulder design. Our findings do not match those reported by De Wilde et al. [8] who reported active shoulder abduction and forward flexion of 175°( range, 160°-180°) and 169°(range, 135°-180°), respectively, in four patients with proximal humeral reconstruction with a reverse prosthesis design. The detachment of the deltoid muscle with THERs as compared with retaining the muscle attachment to the deltoid tuberosity with proximal humeral endoprosthetic replacements may explain this difference in the functional outcome.
Conclusion
THER is an option for reconstruction when the entire humerus requires removal because of extensive tumor of the humerus. When successful, it preserves a functional hand but has some limitations to elbow and shoulder motion. Because these tumors are large and aggressive, the surgeon should carefully review the safety of resection versus amputation because we observed five local recurrences in this relatively small study. We believe this technique can be useful for selected indications, but the surgeon should be aware of the potential complications of infection and shoulder instability in addition to the need to revise the elbow bushings over time. In young children, lengthening of expandable prostheses may be associated with shoulder instability.
